Dr. David Young, President and CSO of ARIUS Research Inc. (TSX-V: ARI), will give a talk on “Functional Anti-cancer Antibodies - A New Age Now Begins” at the European Antibody Congress 2005, October 31 to November 3, 2005 at the Hotel Sofitel Bellecour, Lyon, France. Dr. Young has pioneered a functional approach to the discovery of anti-cancer antibodies through ARIUS’ unique FunctionFIRST(TM) platform. ARIUS antibodies come from a pool that has been screened for the ability to kill or stop cancer cells rather than a pool that was screened to bind to a specified target.
